Cited by 253Neurotransmitter Receptor Influence on BehaviorTreatment of Major DepressionNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 91 of the 92 references it cites were found in a registry or an index.

The 5-HT7 receptor and disorders of the nervous system: an overview

Open access

Hedlund, Peter B.·2009·Psychopharmacology

DOI 10.1007/s00213-009-1626-0PMC PMC2841472

Open this paper in CoChat — free account

Abstract

Rationale The 5-HT(7) receptor is a more recently discovered G-protein-coupled receptor for serotonin. The functions and possible clinical relevance of this receptor are not yet fully understood.Objective The present paper reviews to what extent the use of animal models of human psychiatric and neurological disorders have implicated the 5-HT(7) receptor in such disorders. The studies have used a combination of pharmacological and genetic tools targeting the receptor to evaluate effects on behavior.Results Models of anxiety and schizophrenia have yielded mixed results with no clear role for the 5-HT(7) receptor described in these disorders. Some data are available for epilepsy, migraine, and pain but it is still very early to draw any definitive conclusions. There is a considerable amount of evidence supporting a role for the 5-HT(7) receptor in depression. Both blockade and inactivation of the receptor have resulted in an antidepressant-like profile in models of depression. Supporting evidence has also been obtained in sleep studies. Especially interesting are the augmented effects achieved by combining antidepressants and 5-HT(7) receptor antagonists. The antidepressant effect of amisulpride has been shown to most likely be mediated by the 5-HT(7) receptor.Conclusions The use of pharmacological and genetic tools in preclinical animal models strongly supports a role for the 5-HT(7) receptor in depression. Indirect evidence exists showing that 5-HT(7) receptor antagonism is clinically useful in the treatment of depression. Available data also indicate a possible involvement of the 5-HT(7) receptor in anxiety, epilepsy, pain, and schizophrenia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00213-009-1626-0

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Major depressive disorder
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · cited 1×
“The forced swim test and the tail suspension test are two of the most common behavioral models for evaluating the antidepressant potential of a drug or to evaluate the phenotype of transgenic animals with respect to depression (Cryan et al. 2002; Cryan and Holmes 2005).”
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review
Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484
The ascent of mouse: advances in modelling human depression and anxiety
Cryan, J. F., & Holmes, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1825 · Cited by 1,198
Chronic mild stress-induced anhedonia: A realistic animal model of depression
Willner, P., Muscat, R., & Papp, M. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80194-0 · Cited by 1,160 · cited 1×
“Chronic unpredictable mild stress is a model that attempts to induce a depression-like state in laboratory animals (Willner et al. 1992).”
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
Shapiro, D. A., Renock, S. M., Arrington, E. G., Chiodo, L. A., Liu, L.-X., Sibley, D. R., Roth, B. L., & Mailman, R. B. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300203 · Cited by 982
A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms
Lovenberg, T. W., Baron, B. M., de Lecea, L., Miller, J. D., Prosser, R. A., Rea, M. A., Foye, P. E., Racke, M. M., Slone, A. L., Siegel, B. W., et al. (1993) · Neuron · doi:10.1016/0896-6273(93)90149-l · Cited by 691
Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.
Ruat, M., Traiffort, É., Leurs, R., Tardivel‐Lacombe, J., Díaz, J., Arrang, J., & Schwartz, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8547 · Cited by 630
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
Monsma, F. J., Shen, Y., Ward, R. P., Hamblin, M. W., & Sibley, D. R. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13616-x · Cited by 598
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors
Choudhary, M. S., Craigo, S. C., Sibley, D. R., Roth, B. L., Monsma, F. J., Shen, Y., Uluer, A., & Meltzer, H. Y. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/74zp-ze10 · Cited by 592

Show all 92 references

Sorted by citations

Sleep disturbance as transdiagnostic: Consideration of neurobiological mechanisms
Harvey, A. G., Murray, G., Chandler, R. A., & Soehner, A. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.04.003 · Cited by 609
Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
Sanchez, C., Asin, K. E., & Artigas, F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.07.001 · Cited by 547
Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment
Millan, M. J., Fone, K. C. F., Steckler, T., & Horan, W. P. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.008 · Cited by 376
Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
Loebel, A. D., Cucchiaro, J. B., Silva, R., Kroger, H., Hsu, J., Sarma, K., & Sachs, G. S. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13070984 · Cited by 343
Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study
Suppes, T., Silva, R., Cucchiaro, J., Mao, Y., Targum, S., Streicher, C., Pikalov, A., & Loebel, A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15060770 · Cited by 322
Serotonin receptors involved in antidepressant effects
Artigas, F. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.09.006 · Cited by 311
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function
Barnes, N. M., Ahern, G. P., Bécamel, C., Bockaert, J., Camilleri, M., Chaumont‐Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C. F., Gershon, M. D., et al. (2020) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 274
Anhedonia and Substance Dependence: Clinical Correlates and Treatment Options
Hatzigiakoumis, D. S., Martinotti, G., Giannantonio, M. D., & Janiri, L. (2011) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00010 · Cited by 245
Central 5-HT receptors and their function; present and future
Sharp, T., & Barnes, N. M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108155 · Cited by 239
Head‐twitch response in rodents induced by the hallucinogen 2,5‐dimethoxy‐4‐iodoamphetamine: a comprehensive history, a re‐evaluation of mechanisms, and its utility as a model
Canal, C. E., & Morgan, D. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1333 · Cited by 234
Stress Modulation of Opposing Circuits in the Bed Nucleus of the Stria Terminalis
Daniel, S., & Rainnie, D. G. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.178 · Cited by 224
Brain serotonergic circuitries
Charnay, Y., & Léger, L. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.4/ycharnay · Cited by 211
Serotonin 5-HT7 receptor agents: structure-activity relationships and potential therapeutic applications in central nervous system disorders
Leopoldo, M., Lacivita, E., Berardi, F., Perrone, R., & Hedlund, P. B. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.013 · Cited by 198
Self-citation
Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking
Renner, U., Zeug, A., Woehler, A., Niebert, M., Dityatev, A. E., Dityatev, A. E., Gorinski, N., Guseva, D., Galil, D. A., Fröhlich, M., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.101337 · Cited by 198
Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy
Adelöw, C., Andersson, T., Ahlbom, A., & Tomson, T. (2012) · Neurology · doi:10.1212/wnl.0b013e318245f461 · Cited by 196
HTR7 Mediates Serotonergic Acute and Chronic Itch
Morita, T., McClain, S. P., Batia, L. M., Pellegrino, M., Wilson, S. R., Kienzler, M. A., Lyman, K. A., Olsen, A. S. B., Wong, J. F., Stucky, C. L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.05.044 · Cited by 188
Prefrontal cortex executive processes affected by stress in health and disease
Girotti, M., Adler, S. M., Bulin, S. E., Fucich, E. A., Paredes, D., & Morilak, D. A. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.004 · Cited by 176
Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction
Pehrson, A. L., & Sanchez, C. (2014) · CNS Spectrums · doi:10.1017/s1092852913000540 · Cited by 161
Pharmacological Blockade of 5-HT7 Receptors as a Putative Fast Acting Antidepressant Strategy
Mnie‐Filali, O., Faure, C., Lambás‐Señas, L., Mansari, M. E., Belblidia, H., Gondard, E., Etiévant, A., Scarna, H., Didier, A., Bérod, A., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.13 · Cited by 161
5-HT receptors and reward-related behaviour: A review
Hayes, D. J., & Greenshaw, A. J. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.03.005 · Cited by 151
Targeted Inhibition of Serotonin Type 7 (5-HT7) Receptor Function Modulates Immune Responses and Reduces the Severity of Intestinal Inflammation
Kim, J., Bridle, B. W., Ghia, J., Wang, H., Syed, S. N., Manocha, M. M., Palanivel, R., Shajib, M. S., Wan, Y., Hedlund, P. B., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201887 · Cited by 139
Self-citation
The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants
Köhler, S., Cierpinsky, K., Kronenberg, G., & Adli, M. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115609072 · Cited by 140
Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression: A Double-Blind, Placebo-Controlled Study
DelBello, M. P., Goldman, R., Phillips, D., Deng, L., Cucchiaro, J., & Loebel, A. (2017) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2017.10.006 · Cited by 135
Activation of 5-HT7 Serotonin Receptors Reverses Metabotropic Glutamate Receptor-Mediated Synaptic Plasticity in Wild-Type and Fmr1 Knockout Mice, a Model of Fragile X Syndrome
Costa, L., Spatuzza, M., D’Antoni, S., Bonaccorso, C. M., Trovato, C., Musumeci, S. A., Leopoldo, M., Lacivita, E., Catania, M. V., & Ciranna, L. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.008 · Cited by 134
The Role of 5-Hydroxytryptamine 7 Receptors in the Phencyclidine-Induced Novel Object Recognition Deficit in Rats
Horiguchi, M., Huang, M., & Meltzer, H. Y. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.180638 · Cited by 123
The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment
Meltzer, H. Y., Horiguchi, M., & Massey, B. W. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2137-8 · Cited by 120
Dysfunction of Cortical Dendritic Integration in Neuropathic Pain Reversed by Serotoninergic Neuromodulation
Santello, M., & Nevian, T. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.003 · Cited by 118
Synaptic Remodeling Depends on Signaling between Serotonin Receptors and the Extracellular Matrix
Bijata, M., Labus, J., Guseva, D., Stawarski, M., Butzlaff, M., Dzwonek, J., Schneeberg, J., Böhm, K., Michaluk, P., Rusakov, D. A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.023 · Cited by 122
Effects of chronic stress on cognitive function – From neurobiology to intervention
Girotti, M., Bulin, S. E., & Carreno, F. R. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100670 · Cited by 170
Decreased Exploratory Activity in a Mouse Model of 15q Duplication Syndrome; Implications for Disturbance of Serotonin Signaling
Tamada, K., Tomonaga, S., Hatanaka, F., Nakai, N., Takao, K., Miyakawa, T., Nakatani, J., & Takumi, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015126 · Cited by 116
The 5-HT7 receptor as a mediator and modulator of antidepressant-like behavior
Sarkisyan, G., Roberts, A. J., & Hedlund, P. B. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.01.022 · Cited by 114
Self-citation
Translating the N-methyl-d-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia
Meltzer, H. Y., Rajagopal, L., Huang, M., Oyamada, Y., Kwon, S., & Horiguchi, M. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000928 · Cited by 116
Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations
Cerovecki, A., Musil, R., Klimke, A., Seemüller, F., Haen, E., Schennach, R., Kühn, K.-U., Volz, H.-P., & Riedel, M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0079-5 · Cited by 112
5-HT Receptors and the Development of New Antidepressants
Ślifirski, G., Król, M., & Turło, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169015 · Cited by 117
The 5‐HT7 receptor in learning and memory
Roberts, A. J., & Hedlund, P. B. (2011) · Hippocampus · doi:10.1002/hipo.20938 · Cited by 111
Self-citation
5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders
Ciranna, L., & Catania, M. V. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00250 · Cited by 109
Novel Benzo[b]thiophene Derivatives as New Potential Antidepressants with Rapid Onset of Action
Berrade, L., Aisa, B., Ramírez, M. J., Galiano, S., Guccione, S., Moltzau, L. R., Levy, F. O., Nicoletti, F., Battaglia, G., Molinaro, G., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2000773 · Cited by 109
The Role of Dopamine D3 Receptors in Antipsychotic Activity and Cognitive Functions
Groß, G., & Drescher, K. U. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_7 · Cited by 109
Cellular mechanisms of the 5-HT7receptor-mediated signaling
Guseva, D., Wirth, A., & Ponimaskin, E. G. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00306 · Cited by 101
Effects of the Selective 5-HT7 Receptor Antagonist SB-269970 and Amisulpride on Ketamine-Induced Schizophrenia-like Deficits in Rats
Nikiforuk, A., Kos, T., Fijał, K., Hołuj, M., Rafa, D., & Popik, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066695 · Cited by 99
Serotonergic Mechanisms as Targets for Existing and Novel Antipsychotics
Meltzer, H. Y. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_4 · Cited by 97
Developments in the field of antidepressants, where do we go now?
Artigas, F. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.04.013 · Cited by 100
Second-generation antipsychotics in the treatment of major depressive disorder: current evidence
Han, C., Wang, S., Kato, M., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.811901 · Cited by 92
The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats
Horiguchi, M., & Meltzer, H. Y. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2561-4 · Cited by 89
Genetic and biochemical changes of the serotonergic system in migraine pathobiology
Gasparini, C., Smith, R. A., & Griffiths, L. R. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0711-0 · Cited by 91
Effects of lurasidone in behavioral models of depression. Role of the 5-HT7 receptor subtype
Cates, L. N., Roberts, A. J., Huitrón‐Reséndiz, S., & Hedlund, P. B. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.01.023 · Cited by 87
Self-citation
LP-211 is a brain penetrant selective agonist for the serotonin 5-HT7 receptor
Hedlund, P. B., Leopoldo, M., Caccia, S., Sarkisyan, G., Fracasso, C., Martelli, G., Lacivita, E., Berardi, F., & Perrone, R. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.06.036 · Cited by 83
Self-citation
Pharmacological Stimulation of the Brain Serotonin Receptor 7 as a Novel Therapeutic Approach for Rett Syndrome
Filippis, B. D., Nativio, P., Fabbri, A., Ricceri, L., Adriani, W., Lacivita, E., Leopoldo, M., Passarelli, F., Fuso, A., & Laviola, G. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.105 · Cited by 83
The serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways
Speranza, L., Chambery, A., Domenico, M. D., Crispino, M., Severino, V., Volpicelli, F., Leopoldo, M., Bellenchi, G. C., di Porzio, U., & Perrone‐Capano, C. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.10.026 · Cited by 80
Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor—5-HT1A/5-HT2A/5-HT7 and D2/D3/D4—agents: The synthesis and pharmacological evaluation
Zajdel, P., Marciniec, K., Maślankiewicz, A., Satała, G., Duszyńska, B., Bojarski, A. J., Partyka, A., Jastrzębska‐Więsek, M., Wróbel‐Biedrawa, D., Wesołowska, A., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.12.039 · Cited by 68
Long-lasting beneficial effects of central serotonin receptor 7 stimulation in female mice modeling Rett syndrome
Filippis, B. D., Chiodi, V., Adriani, W., Lacivita, E., Mallozzi, C., Leopoldo, M., Domenici, M. R., Fuso, A., & Laviola, G. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00086 · Cited by 69
Exon‐disrupting deletions of NRXN1 in idiopathic generalized epilepsy
Møller, R. S., Weber, Y. G., Klitten, L. L., Trucks, H., Muhle, H., Kunz, W. S., Mefford, H. C., Franke, A., Kautza, M., Wolf, P., et al. (2013) · Epilepsia · doi:10.1111/epi.12078 · Cited by 69
The serotonin receptor 7 and the structural plasticity of brain circuits
Volpicelli, F., Speranza, L., di Porzio, U., Crispino, M., & Perrone‐Capano, C. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00318 · Cited by 66
Modulatory effects of two novel agonists for serotonin receptor 7 on emotion, motivation and circadian rhythm profiles in mice
Adriani, W., Travaglini, D., Lacivita, E., Saso, L., Leopoldo, M., & Giovanni Laviola, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.09.012 · Cited by 65
The effects of the 5-HT7 receptor on hippocampal long-term potentiation and apoptosis in a rat model of Alzheimer’s disease
Hashemi-Firouzi, N., Komaki‬, A., Asl, S. S., & Shahidi, ‬. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.10.004 · Cited by 58
Effects of the selective 5-HT7 receptor antagonist SB-269970 in animal models of psychosis and cognition
Waters, K. A., Stean, T. O., Hammond, B., Virley, D. J., Upton, N., Kew, J. N. C., & Hussain, I. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.12.009 · Cited by 58
The 5-HT7 receptor as a potential target for treating drug and alcohol abuse
Hauser, S. R., Hedlund, P. B., Roberts, A. J., Sari, Y., Bell, R. L., & Engleman, E. A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00448 · Cited by 56
Self-citation
Impaired visuospatial associative memory and attention in obsessive compulsive disorder but no evidence for differential dopaminergic modulation
Morein-Zamir, S., Craig, K. J., Ersche, K. D., Abbott, S., Muller, U., Fineberg, N. A., Bullmore, E. T., Sahakian, B. J., & Robbins, T. W. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1963-z · Cited by 54
Palmitoylation as a Functional Regulator of Neurotransmitter Receptors
Naumenko, V. S., & Ponimaskin, E. G. (2018) · Neural Plasticity · doi:10.1155/2018/5701348 · Cited by 55
Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT1A and 5-HT7 Antagonists in Animal Models
Pytka, K., Partyka, A., Jastrzębska‐Więsek, M., Siwek, A., Głuch‐Lutwin, M., Mordyl, B., Kazek, G., Rapacz, A., Olczyk, A., Gałuszka, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142499 · Cited by 53
The effect of chronic stimulation of serotonin receptor type 7 on recognition, passive avoidance memory, hippocampal long-term potentiation, and neuronal apoptosis in the amyloid β protein treated rat
Shahidi, ‬., Asl, S. S., Komaki‬, A., & Hashemi-Firouzi, N. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4862-3 · Cited by 54
Altered Serotonin, Dopamine and Norepinepherine Levels in 15q Duplication and Angelman Syndrome Mouse Models
Farook, M. F., DeCuypere, M. G., Hyland, Κ., Takumi, T., LeDoux, M. S., & Reiter, L. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043030 · Cited by 50
Pharmacological Blockade of Serotonin 5-HT7 Receptor Reverses Working Memory Deficits in Rats by Normalizing Cortical Glutamate Neurotransmission
Bonaventure, P., Aluisio, L. E., Shoblock, J. R., Boggs, J. D., Fraser, I. C., Lord, B., Lovenberg, T. W., & Galici, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020210 · Cited by 51
Use of antipsychotics in the treatment of depressive disorders.
Wang, P., & Si, T. (2013) · PubMed Central · doi:10.3969/j.issn.1002-0829.2013.03.002 · Cited by 50
Double‐blind , placebo‐controlled study of lurasidone monotherapy for the treatment of bipolar I depression
Kato, T., Ishigooka, J., Miyajima, M., Watabe, K., Fujimori, T., Masuda, T., Higuchi, T., & Vieta, E. (2020) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13137 · Cited by 49
“This activity has been implicated in antidepressant like effect in animal models.(18) Consistent with this, lurasidone has demonstrated efficacy in animal models of depression.”
Result
5-HT7 receptor signaling: improved therapeutic strategy in gut disorders
Kim, J., & Khan, W. I. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00396 · Cited by 51
A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine
Deardorff, W. J., & Grossberg, G. T. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.960842 · Cited by 49
Differential effects of early environmental enrichment on emotionality related behaviours in Huntington's disease transgenic mice
Renoir, T., Pang, T. Y., Mo, C., Chan, G., Chevarin, C., Lanfumey, L., & Hannan, A. J. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.239798 · Cited by 48
The Role of Serotonin in Axon and Dendrite Growth
Trakhtenberg, E. F., & Goldberg, J. L. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-407178-0.00005-3 · Cited by 48
Peripheral 5-HT7 receptors as a new target for prevention of lung injury and mortality in septic rats
Çadırcı, E., Halıcı, Z., Bayır, Y., Albayrak, A., Karakuş, E., Polat, B., Ünal, D., Atamanalp, S. S., Aksak, S., & Gündoğdu, C. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.04.012 · Cited by 47
Sensitization of restraint-induced corticosterone secretion after chronic restraint in rats: Involvement of 5-HT7 receptors
García‐Iglesias, B. B., Mendoza‐Garrido, M. E., Gutiérrez‐Ospina, G., Rangel‐Barajas, C., Noyola-Díaz, M., & Terrón, J. A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.013 · Cited by 47
Serotonin 5-HT7 Receptor Blockade Reverses Behavioral Abnormalities in PACAP-Deficient Mice and Receptor Activation Promotes Neurite Extension in Primary Embryonic Hippocampal Neurons
Tajiri, M., Hayata‐Takano, A., Seiriki, K., Ogata, K., Hazama, K., Shintani, N., Baba, A., & Hashimoto, H. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9861-y · Cited by 46
Global transcriptomic analysis of zebrafish in response to embryonic exposure to three antidepressants, amitriptyline, fluoxetine and mianserin
Wu, M., Liu, S., Hu, L., Qu, H., Pan, C., Lei, P., Shen, Y., & Yang, M. (2017) · Aquatic Toxicology · doi:10.1016/j.aquatox.2017.09.027 · Cited by 46
5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux
Huang, M., Horiguchi, M., Felix, A. R., & Meltzer, H. Y. (2012) · Neuroreport · doi:10.1097/wnr.0b013e328352de40 · Cited by 45
The multiobjective based design, synthesis and evaluation of the arylsulfonamide/amide derivatives of aryloxyethyl- and arylthioethyl- piperidines and pyrrolidines as a novel class of potent 5-HT7 receptor antagonists
Zajdel, P., Kurczab, R., Grychowska, K., Satała, G., Pawłowski, M., & Bojarski, A. J. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.07.043 · Cited by 45
5-HT7 receptors modulate GABAergic transmission in rat hippocampal CA1 area.
Tokarski, K., Kusek, M., & Hess, G. (2011) · PubMed · Cited by 45
Selective blockade of 5-HT7 receptors facilitates attentional set-shifting in stressed and control rats
Nikiforuk, A. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.09.006 · Cited by 44
Serotonin receptor 5-HT7 regulates morphology and migratory properties of dendritic cells
Holst, K., Guseva, D., Schindler, S., Sixt, M., Braun, A. C., Chopra, H., Pabst, O., & Ponimaskin, E. G. (2015) · Journal of Cell Science · doi:10.1242/jcs.167999 · Cited by 44
Amisulpride promotes cognitive flexibility in rats: The role of 5-HT7 receptors
Nikiforuk, A., & Popik, P. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.04.008 · Cited by 43
Inflammation and peripheral 5-HT7 receptors: The role of 5-HT7 receptors in carrageenan induced inflammation in rats
Albayrak, A., Halıcı, Z., Çadırcı, E., Polat, B., Karakuş, E., Bayır, Y., Ünal, D., Atasoy, M., & Dogrul, A. B. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.05.010 · Cited by 43
S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behavior
Stroth, N., & Svenningsson, P. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.10.003 · Cited by 43
Differential distribution of serotonin receptor subtypes in BNSTALG neurons: Modulation by unpredictable shock stress
Hazra, R., Guo, J. D., Dabrowska, J., & Rainnie, D. G. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.014 · Cited by 42
Efficacy of vortioxetine on the physical symptoms of major depressive disorder
Christensen, M. C., Florea, I., Lindstén, A., & Baldwin, D. S. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118788826 · Cited by 44
5-HT7 receptor activation attenuates thermal hyperalgesia in streptozocin-induced diabetic mice
Ulugöl, A., Oltulu, Ç., Gündüz, Ö., Citak, C., Carrara, R., Shaqaqi, M. R., Sanchez, A. M., & Dogrul, A. B. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.05.006 · Cited by 40
Involvement of 5-HT7 receptors in vortioxetine's modulation of circadian rhythms and episodic memory in rodents
Westrich, L., Haddjeri, N., Dkhissi‐Benyahya, O., & Sánchez, C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.015 · Cited by 39
Effects of 5-HT-7 receptor ligands on memory and cognition
Zareifopoulos, N., & Papatheodoropoulos, C. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.10.011 · Cited by 40
Pharmaco-EEG Studies in Animals: A History-Based Introduction to Contemporary Translational Applications
Drinkenburg, W. H. I. M., Ahnaou, A., & Ruigt, G. S. F. (2015) · Neuropsychobiology · doi:10.1159/000443175 · Cited by 37
The critical role of spinal 5-HT7 receptors in opioid and non-opioid type stress-induced analgesia
Yeşilyurt, Ö., Seyrek, M., Taşdemir, S., Kahraman, S., Deveci, M. S., Karakuş, E., Halıcı, Z., & Dogrul, A. B. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.04.020 · Cited by 38
Arene- and quinoline-sulfonamides as novel 5-HT7 receptor ligands
Zajdel, P., Marciniec, K., Maślankiewicz, A., Paluchowska, M. H., Satała, G., Partyka, A., Jastrzębska‐Więsek, M., Wróbel‐Biedrawa, D., Wesołowska, A., Duszyńska, B., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.09.044 · Cited by 37
Persistent modification of forebrain networks and metabolism in rats following adolescent exposure to a 5-HT7 receptor agonist
Canese, R., Zoratto, F., Altabella, L., Porcari, P., Mercurio, L., de Pasquale, F., Butti, E., Martino, G., Lacivita, E., Leopoldo, M., et al. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3639-6 · Cited by 36
Comparison of 4 Radiolabeled Antagonists for Serotonin 5-HT7Receptor Neuroimaging: Toward the First PET Radiotracer
Lemoine, L., Andriès, J., Bars, D. L., Billard, T., & Zimmer, L. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.089185 · Cited by 36
Fluorinated indole-imidazole conjugates: Selective orally bioavailable 5-HT7 receptor low-basicity agonists, potential neuropathic painkillers
Hogendorf, A. S., Hogendorf, A., Popiołek-Barczyk, K., Ciechanowska, A., Mika, J., Satała, G., Walczak, M., Latacz, G., Handzlik, J., Kieć‐Kononowicz, K., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.03.017 · Cited by 36
The Serotonin-7 Receptor as a Novel Therapeutic Target
Stahl, S. M. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10bs06601gry · Cited by 35
5-HT7 receptor modulates GABAergic transmission in the rat dorsal raphe nucleus and controls cortical release of serotonin
Kusek, M., Sowa, J., Kamińska, K., Gołembiowska, K., Tokarski, K., & Hess, G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00324 · Cited by 33
Rescue of prepulse inhibition deficit and brain mitochondrial dysfunction by pharmacological stimulation of the central serotonin receptor 7 in a mouse model of CDKL5 Deficiency Disorder
Vigli, D., Rusconi, L., Valenti, D., Montanara, P. L., Cosentino, L., Lacivita, E., Leopoldo, M., Amendola, E., Gross, C. T., Landsberger, N., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.10.018 · Cited by 33
Receptor mechanisms of antipsychotic drug action in bipolar disorder – focus on asenapine
Reynolds, G. P. (2011) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125311430112 · Cited by 34
Search for a 5-CT alternative. In vitro and in vivo evaluation of novel pharmacological tools: 3-(1-alkyl-1 H -imidazol-5-yl)-1 H -indole-5-carboxamides, low-basicity 5-HT 7 receptor agonists
Latacz, G., Hogendorf, A. S., Hogendorf, A., Lubelska, A., Wierońska, J. M., Woźniak, M., Cieślik, P., Kieć‐Kononowicz, K., Handzlik, J., & Bojarski, A. J. (2018) · MedChemComm · doi:10.1039/c8md00313k · Cited by 32
Therapeutic potential of serotonin 4 receptor for chronic depression and its associated comorbidity in the gut
Agrawal, L., Korkutata, M., Vimal, S. K., Yadav, M. K., Bhattacharyya, S., & Shiga, T. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107969 · Cited by 32
Estradiol modulation of cortical, striatal and raphe nucleus 5-HT1A and 5-HT2A receptors of female hemiparkinsonian monkeys after long-term ovariectomy
Sanchez, M. G. D. B., Estrada-Camarena, E. M., Bélanger, N., Morissette, M., & Paolo, T. D. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.024 · Cited by 29
Evidence of an inverse correlation between serotonergic activity and spreading depression propagation in the rat cortex
Guedes, R. C. A., de Araújo, M. D. G. R., Verçosa, T. C., Bion, F. M., de Sá, A. L., Pereira, A., & Abadie‐Guedes, R. (2017) · Brain Research · doi:10.1016/j.brainres.2017.07.011 · Cited by 30

Authors: Hedlund, P. B.
Affiliations: Scripps Research Institute (US)
Corresponding author: Hedlund, Peter B.
Venue: Psychopharmacology
Publisher: Springer Science and Business Media LLC
Published: 2009-08-01
Volume: 206
Issue: 3
Pages: 345-354
ISSN: 0033-3158 (ISSN-L)
1432-2072
DOI: 10.1007/s00213-009-1626-0
PMC: PMC2841472
OpenAlex: W1966819687
Cited by: 239
References: 92
Citations by year: 2026: 6 · 2025: 7 · 2024: 11 · 2023: 4 · 2022: 13 · 2021: 2 · 2020: 11 · 2019: 7 · 2018: 13 · 2017: 19 · 2016: 11 · 2015: 25 · 2014: 19 · 2013: 23 · 2012: 31
FWCI: 2.09
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Psychopharmacology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Mental Health (MH73923, R01MH073923)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: 5-HT7 receptor, serotonin, G protein-coupled receptors, depression, antidepressant-like effects, 5-HT7 receptor antagonists, amisulpride, anxiety, schizophrenia, epilepsy, migraine, pain, sleep, animal models of psychiatric disorders
MeSH terms: Animals, Antidepressive Agents, Disease Models, Animal, Humans, Nervous System Diseases, Receptors, Serotonin, Serotonin Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The 5-HT7 receptor and disorders of the nervous system: an overview

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks